What is CBD? Let Us Refer CBD’s Brief History, Its Discovery And A Brief Timeline

CBD, the way we know and use it today, is not the discovery of this generation. The usage of CBD takes back to many generations, but in an alternate form. Let us have a look at CDB’s brief timeline, its discovery, and how its journey began to date.

Brief History

Chinese Emperor named Sheng Nung was the first to have the medicinal benefits of cannabis. He infused the cannabis plant in tea to cure diseases such as malaria and gout, enhance memory, and treat rheumatism.

Till 1901, Queen Victoria is believed to have consumed cannabis for her menstrual cramps. It was used for therapeutic resources. However, modern medicine can be used in various forms such as cbd para vapear [English Meaning = CBD oil], gummies, and so on. JustCBD with the help of digitalization tries to reach every corner of the world to provide health benefits and wellness products. JustCBD creates a meeting point for companies and end-users so that they can avail CBD benefits and explore them in-depth.

The base of the modern research on CBDs was as a result of the efforts made by William B. O’Shaughnessy, the Irish physician during 1839. He had initiated the medicinal applications of the CBDs and benefits it associates.

Chronological Timeline.

1940: Robert S. Cahn, the British chemist was the first to discover fully formed cannabinoid in 1940.

1942: Later on, in 1942, Roger Adams isolated cannabidiol (Cannabis sativa L.Plant), further discovering Tetrahydrocannabinol (THC). He spent several years in the research of marijuana’s chemistry. However, he was unaware of the exact chemical compound and did not describe the chemical structure that he had separated.

1946: Dr. Walter S. Loewe, conducted the test and kept it well documented. He experimented with the chemical structure of the CBD on animals, mostly on mice and rabbits. The results of the experiment were:

  • THC caused catalepsy and central excitant action in mice.
  • With CBD, there was no change in the behavior

Since the chemical structure was not properly identified, the exact change by the type of structure and its reaction was difficult to conclude.

1964: Dr. Raphael Mechoulam, Israel’s scientist was successful in identifying CBD’s stereochemistry. With his help, it was clear that THC has a psychoactive compound and CBD is a non-intoxicating compound.

In the late 1960s, when the test was conducted on primates, it was confirmed that THC caused intoxication and sedation instead of CBD.

1970: During this early decade, the prices of marijuana shot as soon as the medicinal properties were explored further by Dr. Mechoulam and later released by British Pharmacopoeia. The use of cannabis for the medicinal purpose was declared as legal first by Mexico, US.


In 1980, Mechoulam jointly with South American researchers, took another leap on the study of cannabis and epilepsy. His study on epilepsy proved to a boon for the millions suffering from frequent seizures. However, the publication was unnoticed by the leading pharmaceutical companies in the 1980s, more because of a stigma associated with cannabis.


Starting in 1996, various states in the US, legalized the use of marijuana for medicinal use. The first being California. Considering neuroprotectant, CBD was patented by the US in 2003. This became the rise of legalization and enacting various laws to make CBD available for the public legally.


This year marks a historic event for the CBD with the story of Charlotte Figi. She was born with Dravet Syndrome and no medication could work. She would have 300 seizures in a week. After the use of high-strain CBD, her seizures were decreased to almost 2-3 seizures in a month.

Present scenario:

US acknowledged the benefits of the CBD for medicinal use and thus started its process for governing the use by the FDA. Various strains such as hemp-derived CBD is already legalized. Various other CBD products are in the sale online and completely legal to use it.

Thus, CBD has a long way to go. This is just a tip on the iceberg. The projection conducted by leading analysts predicts the market to cross $22 billion by 2022.